Health and Family Welfare Government Departments Closing in 6 days TDR #56012349

Bids Are invited for System Suitability Test Solution

Issued by Government Departments · Ghaziabad, Uttar Pradesh
Tender Value
Ref. Documents
Estimated cost
Bid Submission
07 Jul 2026
6 days left
EMD
25000
Bank guarantee accepted
Document Fee
Ref. Documents
Non-refundable
Tender Type
Gem

Tender Overview

Competition Type
NCB
Bidding Type
Tender
Location / State
Ghaziabad → Uttar Pradesh
EMD Exemption
Available
Quantity
11600

Project Description

Bids Are invited for System Suitability Test Solution Acarbose - Containing Impurity A B C D E F And G , Acyclovir - Containing Impurity B J K N O And P , Amorolfine Hcl - Containing Impurity D E I And J , Atazanavir Sulphate - Containing Impurity Rs Ss Diastreomer Sr Ss Diastrreomer , Atenolol - Containing Impurity B F G I And H , Beclomethasone Dipropionate - Containing Impurity A B C L And M , Bromocriptine - Containing Impurity A And B , Bromhexine - Containing Impurity C And D , Buprenorphine Hcl - Containing Impurity A B F G H And J , Carvedilol Tablet - Containing Impurity A And D , Chlorhexidine - Sst Mixture , Clindamycin Phophate - Containing Impurity B E F G I J K And L , Clobetasol Propionate - Containing Impurity A B D And E , Colchicine - Containing Impurity A E And G , Dolutegravir Sodium - Containing Dolutegravir 4-Fluro Impurity Isomer 1 Isomer 2 And Enantiomer , Dolutegravir Sodium - For Peak Identification Containing Dolutegravir Sodium And Impurity A B And D , Domperidone - Containing Impurity A And D Plus E , Doxycycline Hcl - Containing Impurity A B C And F , Duloxetine - Containing Impurity F , Ethambutol - Containing Rs Isomer , Famotidine - Containing Impurity A B C D E F And G , Finasteride - For Peak Identification Containing Impurity A And C , Fingolimod - Containing Impurity Mixture A Mixture Containing Fingolimod Hydrochloride Fingolimod Hexyl Homolog Fingolimod Heptyl Homolog O-Acetyl Fingolimod Fingolimod Nonyl Homolog Fingolimod Decyl Homolog 3-Phenethyl Fingolimod Analog And 2-Phenethyl Fingolimod Analog , Flurbiprofen - Containing Impurity B , Fusidic Acid - For Peak Identification Containing Impurity A B C D F G H And N , Fusidic Acid - For Impurity Mixture Containing Impurity I K L And M , Glimepride - Containing Impurity B C And D , Griserfulvin - Containing Impurity A B And C , Hysoscine Butyl Bromide - Containing Impurity A , Imatinib - Containing Impurity A B C D And J , Ketoconazole - Impurity Mixture Containing Impurity C And D , Lincomycin - Containing Impurity A B And C , Loratadine - Containing Impurity A And E , Minocycline Hcl - Containing Impurity A B C E F G And H , Mometasone Furoate - Containing Impurity C And J , Morphine - Containing Impurity B C E And F , Naloxone - For Peak Identification Containing Impurity A B C D E And F , Norfloxacin - Containing Impurity A E And H , Nortriptyline Hcl - Containing Impurity D , Oxytetracycline - Containing Impurity A B C D And E , Perindopril Erbumine - For Peak Identification Containing Impurity B E F H And K , Pilocarpine Hcl - Containing Impurity A , Prednisolone - For Peak Identification Containing Impurity F And J , Progesterone - For Peak Identification Containing Impurity B C G I And M , Rocuronium Bromide - For Peak Identification Containing Impurity A B C F G And H , Rosuvastatin - Containing Impurity Mixture A Mixture Containing Rosuvastatin Calcium Rosuvastatin Ketone Rosuvastatin Lactone And Rosuvastatin Diastereomers , Rupatadine Fumarate - Containing Impurity A And B , Salbutamol - For Peak Identification Containing Impurity C F N O And P , Sumatriptan - Containing Impurity A And H , Tamoxifen Citrate - For Peak Performance Test Iprs Containing Impurity A And F , Thiamine - Containing Impurity A B And C , Tibolone - Impurity Standard (Containing B C And 1 Percent Weight By Weight Impurity A , Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate Tablets - Containing Impurity I And H , Tiotropium - Impurity Mixture Containing Impurity G And H , Triamcinolone Acetonide - Containing Impurity B And C , Vancomycin - Containing Impurity A B C J K And M , Venlafaxime - Containing Impurity D And F , Zuclopenthixol Decanoate - Containing Impurity A B And C Total Quantity : 11600

BOQ

Sl. No. Item TitleItem Description
1AcarboseContaining Impurity A B C D E F and G
2AcyclovirContaining Impurity B J K N O and P
3Amorolfine HClContaining Impurity D E I and J
4Atazanavir SulphateContaining Impurity RS SS Diastreomer SR SS Diastrreomer
5AtenololContaining Impurity B F G I and H
6Beclomethasone DipropionateContaining Impurity A B C L and M
7BromocriptineContaining Impurity A and B
8BromhexineContaining Impurity C and D
9Buprenorphine HClContaining Impurity A B F G H and J
10Carvedilol TabletContaining Impurity A and D
11ChlorhexidineSST Mixture
12Clindamycin PhophateContaining Impurity B E F G I J K and L
13Clobetasol PropionateContaining Impurity A B D and E
14ColchicineContaining Impurity A E and G
15Dolutegravir SodiumContaining dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer
16Dolutegravir Sodiumfor peak identification Containing dolutegravir sodium and Impurity A B and D
17DomperidoneContaining Impurity A and D plus E
18Doxycycline HClContaining Impurity A B C and F
19DuloxetineContaining Impurity F
20EthambutolContaining RS isomer
21FamotidineContaining Impurity A B C D E F and G
22Finasteridefor peak identification Containing impurity A and C
23FingolimodContaining impurity Mixture A mixture containing Fingolimod hydrochloride Fingolimod hexyl homolog Fingolimod heptyl homolog O-acetyl fingolimod Fingolimod nonyl homolog Fingolimod decyl homolog 3-Phenethyl fingolimod analog and 2-Phenethyl fingolimod analog
24FlurbiprofenContaining Impurity B
25Fusidic Acidfor peak identification Containing Impurity A B C D F G H and N
26Fusidic AcidFor Impurity Mixture Containing Impurity I K L and M
27GlimeprideContaining Impurity B C and D
28GriserfulvinContaining Impurity A B and C
29Hysoscine Butyl BromideContaining Impurity A
30ImatinibContaining Impurity A B C D and J
31KetoconazoleImpurity Mixture Containing Impurity C and D
32LincomycinContaining Impurity A B and C
33LoratadineContaining Impurity A and E
34Minocycline HClContaining Impurity A B C E F G and H
35Mometasone furoateContaining Impurity C and J
36MorphineContaining Impurity B C E and F
37Naloxonefor peak identification Containing Impurity A B C D E and F
38NorfloxacinContaining Impurity A E and H
39Nortriptyline HClContaining Impurity D
40OxytetracyclineContaining Impurity A B C D and E
41Perindopril erbuminefor peak identification Containing Impurity B E F H and K
42Pilocarpine HClContaining Impurity A
43Prednisolonefor peak identification Containing Impurity F and J
44Progesteronefor peak identification Containing Impurity B C G I and M
45Rocuronium Bromidefor peak identification Containing Impurity A B C F G and H
46RosuvastatinContaining Impurity mixture A mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers
47Rupatadine FumarateContaining Impurity A and B
48Salbutamolfor peak identification Containing Impurity C F N O and P
49SumatriptanContaining Impurity A and H
50Tamoxifen citrateFor peak Performance Test IPRS Containing Impurity A and F
51ThiamineContaining Impurity A B and C
52TiboloneImpurity Standard (Containing B C and 1 percent weight by weight impurity A
53DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETSContaining Impurity I and H
54TiotropiumImpurity Mixture Containing Impurity G and H
55Triamcinolone AcetonideContaining Impurity B and C
56VancomycinContaining Impurity A B C J K and M
57VenlafaximeContaining Impurity D and F
58Zuclopenthixol DecanoateContaining Impurity A B and C

AI Tender Summary

OUR REF NO 56012349
AUTHORITY Government Departments
TENDER VALUE Ref. Documents
LAST DATE 07-07-2026
Authority
Authority Name Department Of Health And Family Welfare
Work Description Bids Are invited for System Suitability Test Solution Acarbose - Containing Impurity A B C D E F And G , Acyclovir - Containing Impurity B J K N O And P , Amorolfine Hcl - Containing Impurity D E I And J , Atazanavir Sulphate - Containing Impurity Rs Ss Diastreomer Sr Ss Diastrreomer , Atenolol - Containing Impurity B F G I And H , Beclomethasone Dipropionate - Containing Impurity A B C L And M , Bromocriptine - Containing Impurity A And B , Bromhexine - Containing Impurity C And D , Buprenorphine Hcl - Containing Impurity A B F G H And J , Carvedilol Tablet - Containing Impurity A And D , Chlorhexidine - Sst Mixture , Clindamycin Phophate - Containing Impurity B E F G I J K And L , Clobetasol Propionate - Containing Impurity A B D And E , Colchicine - Containing Impurity A E And G , Dolutegravir Sodium - Containing Dolutegravir 4-Fluro Impurity Isomer 1 Isomer 2 And Enantiomer , Dolutegravir Sodium - For Peak Identification Containing Dolutegravir Sodium And Impurity A B And D , Domperidone - Containing Impurity A And D Plus E , Doxycycline Hcl - Containing Impurity A B C And F , Duloxetine - Containing Impurity F , Ethambutol - Containing Rs Isomer , Famotidine - Containing Impurity A B C D E F And G , Finasteride - For Peak Identification Containing Impurity A And C , Fingolimod - Containing Impurity Mixture A Mixture Containing Fingolimod Hydrochloride Fingolimod Hexyl Homolog Fingolimod Heptyl Homolog O-Acetyl Fingolimod Fingolimod Nonyl Homolog Fingolimod Decyl Homolog 3-Phenethyl Fingolimod Analog And 2-Phenethyl Fingolimod Analog , Flurbiprofen - Containing Impurity B , Fusidic Acid - For Peak Identification Containing Impurity A B C D F G H And N , Fusidic Acid - For Impurity Mixture Containing Impurity I K L And M , Glimepride - Containing Impurity B C And D , Griserfulvin - Containing Impurity A B And C , Hysoscine Butyl Bromide - Containing Impurity A , Imatinib - Containing Impurity A B C D And J , Ketoconazole - Impurity Mixture Containing Impurity C And D , Lincomycin - Containing Impurity A B And C , Loratadine - Containing Impurity A And E , Minocycline Hcl - Containing Impurity A B C E F G And H , Mometasone Furoate - Containing Impurity C And J , Morphine - Containing Impurity B C E And F , Naloxone - For Peak Identification Containing Impurity A B C D E And F , Norfloxacin - Containing Impurity A E And H , Nortriptyline Hcl - Containing Impurity D , Oxytetracycline - Containing Impurity A B C D And E , Perindopril Erbumine - For Peak Identification Containing Impurity B E F H And K , Pilocarpine Hcl - Containing Impurity A , Prednisolone - For Peak Identification Containing Impurity F And J , Progesterone - For Peak Identification Containing Impurity B C G I And M , Rocuronium Bromide - For Peak Identification Containing Impurity A B C F G And H , Rosuvastatin - Containing Impurity Mixture A Mixture Containing Rosuvastatin Calcium Rosuvastatin Ketone Rosuvastatin Lactone And Rosuvastatin Diastereomers , Rupatadine Fumarate - Containing Impurity A And B , Salbutamol - For Peak Identification Containing Impurity C F N O And P , Sumatriptan - Containing Impurity A And H , Tamoxifen Citrate - For Peak Performance Test Iprs Containing Impurity A And F , Thiamine - Containing Impurity A B And C , Tibolone - Impurity Standard (Containing B C And 1 Percent Weight By Weight Impurity A , Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate Tablets - Containing Impurity I And H , Tiotropium - Impurity Mixture Containing Impurity G And H , Triamcinolone Acetonide - Containing Impurity B And C , Vancomycin - Containing Impurity A B C J K And M , Venlafaxime - Containing Impurity D And F , Zuclopenthixol Decanoate - Containing Impurity A B And C Total Quantity : 11600
Basic Detail
Tender No GEM/2026/B/7668664
Bidding Type Tender
Location
City Ghaziabad
State Uttar Pradesh
Key Dates
Publish Date 16 Jun 2026
Submission Date 07 Jul 2026
Open Date 07 Jul 2026
Finance
Tender Value Ref. Documents
Tender Fee Ref. Documents
EMD 25000
Exemption Available
Document List
7b920a94-6e73-47cf-8041-76841ba748f2.pdf
9473196_Boq_1.xlsx
gem_tender_for_sst_solutions_2026-06-16-10-49-30_91f8ab8f55cfbca20912aa2218a6a2cd.pdf
Int_Pact_8b59837c-40e6-4e8b-91c21781594631006_ipcpvpi_gaurav.pdf

Unlock Full AI Tender Summary

Get instant access to the complete AI-generated analysis — scope, eligibility, timeline & more.

Instant Access Secure Free
Your details are secure and used only for document delivery.

Tender Timeline

Jun 16, 2026
11:30 IST

Tender Published

Tender notice published.

Completed
Jul 07, 2026
17:00 IST

Bid Submission Deadline

Online submission via eProcurement portal.

Upcoming · 6 days
Jul 07, 2026

Bid Opening Date

Technical bids will be opened and evaluated.

Upcoming · 6 days

Tender Documents

Download All (ZIP) ↓
pdf

7b920a94-6e73-47cf-8041-76841ba748f2.pdf

xlsx

9473196_Boq_1.xlsx

pdf

gem_tender_for_sst_solutions_2026-06-16-10-49-30_91f8ab8f55cfbca20912aa2218a6a2cd.pdf

pdf

Int_Pact_8b59837c-40e6-4e8b-91c21781594631006_ipcpvpi_gaurav.pdf

TenderDetail
Loading tenders